1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Dr. Agarwal's Health Care Ltd.

Dr. Agarwal's Health Care Ltd.

475.25
INR
+6.90
(+1.47%)
128.67BMarket Cap
Oct 29Next Earn
Dr. Agarwal's Health Care Ltd.
BSE:AGARWALEYE
(Bombay Stock Exchange)

Recent

price

475.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
2026
TTM
INR
22.01
32.18
42.03
57.27
65.67
- -
Revenue per Share
1.19
2.98
2.63
2.8
4.21
- -
Basic EPS, GAAP
5.2
7.38
10.95
12
16.41
- -
Free Cash Flow per Basic Share
- -
0.01
0.02
0.03
0.03
- -
Dividend per Share
6.72
19.93
42.4
59.09
63.93
- -
Book Value per Share
0.81
4.37
19.3
21.35
27.54
- -
Tangible Book Value per Share
316
316
316
298
316
316
Basic Weighted Avg Shares
6,953
10,165
13,277
17,046
20,771
- -
Sales/Revenue/Turnover
13.81
15.11
15.2
14.59
14.78
- -
Operating Margin (%)
940
1,283
1,704
2,307
2,762
- -
Depreciation Expense
377
941
831
835
1,332
- -
Net Income, GAAP
23.96
- -
32.38
30.97
32.38
- -
Effective Tax Rate (%)
5.42
9.26
6.26
4.9
6.41
- -
Profit Margin (%)
215
89
3,588
3,163
1,115
- -
Working Capital
5,555
7,617
8,354
8,075
9,514
- -
LT Debt
2,338
6,591
13,795
19,268
21,197
- -
Total Equity
- -
- -
6.95
6.18
6.77
- -
Return on Invested Capital (%)
- -
- -
7.03
5.01
5.25
- -
Return on Capital (%)
- -
22.35
8.44
5.21
6.84
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
1,148
- -
LT Borrowings
- -
1,333
- -
LT Finance Leases
- -
8,181
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
316
317
317
Market Capitalization
160,988
128,671
151,518

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
5,730
- -
Cash, Cash Equivalents & STI
- -
2,838
- -
Accounts Receivable, Net
- -
1,609
- -
Inventories
- -
940
- -
Total Current Liabilities
- -
4,615
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,148
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
10.01%
Free Cash Flow
- -
- -
45.32%
Net Income, GAAP
- -
- -
59.59%
Sales/Revenue/Turnover
- -
- -
21.85%
Total Cash Common Dividend
- -
- -
37.97%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
4,035
4,155
4,307
4,602
17,046
2026
4,874
- -
5,299
5,641
20,771
2027
6,140
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.38
0.52
0.71
1.04
2.8
2026
0.95
- -
1.07
1.25
4.21
2027
1.43
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.03
2026
- -
- -
- -
- -
0.03
2027
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Dr. Agarwal's Health Care Limited operates as a specialized eye care company providing comprehensive ophthalmology services and products. Its core offerings include cataract surgeries, refractive surgeries, corneal, retinal, glaucoma, squint, and oculoplasty surgeries; consultations; clinical investigations; diagnoses; and non-surgical treatments. The company also markets optical products such as contact lenses, accessories, and eye-care-related pharmaceuticals. It operates a hub-and-spoke model with tertiary centers including centers of excellence in Chennai, Tirunelveli, and Cuttack, supported by secondary and primary centers. Founded in 2010 and headquartered in Chennai, India, Dr. Agarwal's Health Care has expanded its geographic presence into Telangana, Karnataka, and several other Indian states. The company serves a broad customer base requiring comprehensive eye care across surgery, diagnostics, and retail optical services. Recent major developments include the approved merger of its listed parent company Dr. Agarwal's Health Care Limited with its subsidiary Dr. Agarwal's Eye Hospital Ltd to create a simpler and more efficient group structure aimed at unlocking combined business potential. Additionally, the company secured significant funding in 2025, including a loan of approximately $31 million to support expansion in India and emerging markets. These strategic moves reflect the company's commitment to scaling operations and enhancing service delivery across its comprehensive eye care segments. Overall, Dr. Agarwal's Health Care Limited is a leading single-specialty healthcare provider in ophthalmology, combining surgical and non-surgical eye care with retail optical products, supported by a network of specialized facilities predominantly in India and select international markets. It continues to invest in growth through strategic mergers and funding to consolidate its market position and advance innovation in eye care services.